In the current study, we have observed that T-ALL cells with PTEN wild type (WT) are more sensitive to ASNase (compared to the PTEN-null cells) and that resistance to ASNase in the PTEN-null cells could be reversed by inhibiting Akt signaling. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.